Catering to the complexity and molecular diversity of modern pharmaceuticals requires an enormous amount of global coordination. Organizations around the world need to work together to supply everything from starting materials to advanced API intermediates for the production of both branded and generic drugs.
- With a sizable global footprint and solid partnerships with pharmaceutical intermediates manufacturers, Tetra Med Sciences safely manages schedules, logistics, timelines, and international distribution.
- Tetra Med Sciences understands that CMOs and innovators often have special standards for raw material and API intermediate quality, based on their capabilities and end-products.
- With our breadth of offerings, excellent quality assurance, and premier customer service, Tetra Med Sciences optimizes your pharmaceutical intermediate supply chain and solve challenges along the way.
| Sl.NO | Chemical Name | CAS Number | API Name |
|---|---|---|---|
| 1 | 2,6-Dichloro-3,5-dimethoxyaniline | 872509-56-3 | Infigratinib |
| 2 | 6-Chloro-N-methylpyrimidin-4-amine | 65766-32-7 | |
| 3 | 3-(5-Hydroxy-2-pyrimidinyl)benzoic acid (3-(5-Hydroxypyrimidin-2-yl)benzoic acid) | 1092568-86-9 | Tepotinib |
| 4 | 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid | 264264-32-6 | |
| 5 | Methanaminium, 1-[[2-(dimethylamino)-1-[(dimethyliminio)methyl]ethenyl]amino]-N,N-dimethyl-, hexafluorophosphate(1-) (1:2) | ||
| 6 | Intermediates | Zanubrutinib |